About CN Bio

 

We help Pharma and Biotech Companies to improve the effectiveness and efficiency of preclinical drug testing and Academia to discover more about human physiology.

Our microphysiological systems (also known as Organ-on-Chip) bring precision and human-relevant data to drug development and other commercial or research scenarios. They enable researchers to work on novel and innovative human modalities including gene editing, therapeutic antibodies, proteins and cellular therapies.

Our vision

CN Bio’s vision is for PhysioMimix™ technology to be the engine that drives the development of new medicines and consumer products which are safer and more effective by enabling a new understanding of human biology in the laboratory. Our human tissue-based studies provide quicker, more predictive data than traditional approaches, enabling teams to decide with confidence which projects to invest in.

Our values

Our core values represent the foundations upon which our organisation is built. Collectively, they define who we are, describe our culture and shape what we aspire to be.

Our technology

We work closely with leading academic bio-engineering groups including MIT (Massachusetts Institute of Technology) and Vanderbilt University. CN Bio has been awarded numerous prestigious grants by sponsors including Innovate UK and was a participant in the DARPA (United States Defence Advanced Research Projects agency) Body-on-a-Chip project.

Our technology is being used by scientists at the US FDA (Food and Drug Administration) to investigate drug metabolism, toxicity and drug-drug interactions.

COMPANY HEAD OFFICE INFORMATION:

332 Cambridge Science Park
Milton Road
Cambridge
CB4 0WN

+44 (0) 1223 737941
enquiries@cn-bio.com

FOR PRODUCT, SERVICES AND MARKETING ENQUIRIES:

+44 (0) 1223 737941
enquiries@cn-bio.com

CN BIO INNOVATIONS LIMITED REGISTERED OFFICE:

30 Upper High Street, Thame,
Oxfordshire, OX9 3EZ.

Registered No. 06517359.
VAT No. 978184563